四方股份(601126.SH):擬以2070萬元參與投設科改示範行動基金1號
格隆匯8月1日丨四方股份(601126.SH)公佈,公司擬參與投資設立科改示範行動基金1號(有限合夥)(以登記機關最終核准登記的名稱為準)(“合夥企業”、“本基金”),公司作為有限合夥人計劃出資規模為人民幣2070萬元。其投資目標為 “百户科技型企業深化市場化改革提升自主創新能力專項行動”入選企業等。
公司參與投資設立本基金,有利於公司與業務合作方構建更深層次的合作關係,能夠促進雙方在技術、市場、資本等多方面融合,提升雙方的科技創新與成果轉化能力,為未來發展提供有力支撐,實現合作共贏。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.